Kenneth Cole and Zynga to Bring First-of-its-Kind Pride Month Partnership to Rollic's Hyper-Casual Game High Heels!
27.5.2021 16:00:00 EEST | Business Wire | Press release
Kenneth Cole and Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment, today announced a partnership to debut the Kenneth Cole PRIDE 2021 collection in the hit hyper-casual game High Heels!. This collaboration marks the first time that Kenneth Cole’s iconic street-smart style will be featured in a mobile game. For the first two weeks of June, gamers will be able to play with pride as they outfit their character and strut the virtual runway in product from the Kenneth Cole PRIDE 2021 collection, including the brand’s iconic KAM sneakers, shirts that proudly state “Being Different is What We Have in Common” and other accessories such as sunglasses, watches and mask lanyards.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210527005009/en/
Kenneth Cole and Zynga to Bring First-of-its-Kind Pride Month Partnership to Rollic's Hyper-Casual Game High Heels! (Graphic: Business Wire)
At Kenneth Cole, there has always been a rich history of supporting public health and civil liberties. For almost 40 years, the man and the brand have nurtured and maintained a global culture of equity and inclusion. In 2020, Kenneth Cole founded The Mental Health Coalition, whose mission is to build a like-minded community that will work together to destigmatize all mental health conditions, enabling equitable access to vital resources and support for all. For every PRIDE product purchased on kennethcole.com, a percentage of net sales will be donated to The Mental Health Coalition. MHC is proud to offer resources specific to LGBTQ+ communities, including an LGBTQ+ mental health guide and the ability to connect with its member organizations for support.
“As a brand, we have been supporting equal rights for the LGBTQ+ community for almost 30 years. For our latest initiative, in recognition of Pride, we are proud to partner with Zynga, a company with shared values, to further highlight the importance of inclusion and acceptance,” said Kenneth Cole, Chairman and Chief Creative Officer of Kenneth Cole Productions, Inc. “We are including our PRIDE product in High Heels!, allowing millions of people to experience celebrating Pride, and as a reminder that ‘being different is what we have in common.’”
“At Zynga we believe, unequivocally, that our strength is in our diversity and that we are called to celebrate our differences. We are proud to stand in solidarity with the LGBTQ+ community in celebration of Pride Month,” said Frank Gibeau, Chief Executive Officer of Zynga. “We’re thrilled to be partnering with a revered, boundary-pushing brand like Kenneth Cole to increase representation in our games and empower players to show their pride, spirit and fashion in High Heels!; it’s a perfect fit.”
Developed by Rollic, a subsidiary of Zynga, High Heels! has been downloaded over 60 million times and has been enthusiastically received all around the world. In the game, players maneuver an increasingly challenging catwalk in high heels, which stack higher as they complete levels. The stakes rise as players progress through a series of worldwide fashion shows in global cities including London, Beijing, Paris and New York. Earning access to new customization elements as they advance, players can update their character with new clothing, fashion, hairstyles and shoes.
High Heels! is available to download for free on the App Store as well as Google Play. Kenneth Cole PRIDE product is available on KennethCole.com. The 2021 PRIDE capsule includes:
- KAM sneaker with rainbow stripe
- T-shirt with rainbow graphic “Being Different is What We Have in Common”
- Mask lanyards in rainbow
- Sunglasses
- Watch
Editor’s Note:
Photos of the collection and other key art from High Heels! can be downloaded here:
https://www.dropbox.com/sh/9kkjzkthgtwwh4y/AACIjzTt9saFabc74KqRF6gFa?dl=0
About Zynga Inc.
Zynga is a global leader in interactive entertainment with a mission to connect the world through games. To date, more than one billion people have played Zynga’s franchises including CSR Racing™, Empires & Puzzles™, Merge Dragons!™, Merge Magic!™, Toon Blast™, Toy Blast™, Words With Friends™ and Zynga Poker™. Zynga’s games are available in more than 150 countries and are playable across social platforms and mobile devices worldwide. Founded in 2007, the company is headquartered in San Francisco with locations in the U.S., Canada, U.K., Ireland, India, Turkey and Finland. For more information, visit www.zynga.com or follow Zynga on Twitter, Instagram, Facebook or the Zynga blog.
About Kenneth Cole Productions, Inc.
Kenneth Cole is an American designer, social activist, and visionary who believes business and philanthropy are interdependent. His global company, Kenneth Cole Productions, creates modern, functional, and versatile footwear, clothing, and accessories for inspirational urban lifestyles under the labels Kenneth Cole New York, Reaction Kenneth Cole, and Unlisted, as well as footwear under the label Gentle Souls. The company has also granted a wide variety of third party licenses for the production of men’s and women's apparel, fragrances, watches, jewelry, eyewear, and several other accessory categories, including children’s footwear. The company's products are distributed through department stores, better specialty stores, company-owned retail stores and its e-commerce website.
Over 35 years ago, Kenneth Cole leveraged his passion and unique brand platform to make a meaningful impact on people’s wardrobes, as well as communities in need. He did what others didn’t and said what others wouldn’t. Today, The Kenneth Cole Foundation remains committed to helping communities in need by supporting Public Health and Civil Liberties.
About Rollic
Founded in December 2018, Rollic is an Istanbul-based game developer and publisher, focused on free-to-play hyper-casual games for iOS and Android. Games released by Rollic include Blob Runner 3D, Flipper Dunk, Go Knots 3D, High Heels!, Onnect – Pair Matching Puzzle, Pixel Shot 3D, Picker 3D, Repair Master 3D, Tangle Master 3D, Water Shooty and Wheel Smash. Rollic is committed to producing massively appealing global titles while building a thriving developer ecosystem in the gaming industry. Rollic was acquired by Zynga, a global leader in interactive entertainment, in October 2020. For more information, visit www.rollicgames.com or follow Rollic on Facebook, LinkedIn, Instagram, Twitter or the Rollic blog.
Forward Looking Statements
This press release contains forward-looking statements, relating to, among other things, events and featuring in the game High Heels!. Forward-looking statements often include words such as “outlook,” “projected,” “planned,” “intends,” “will,” “anticipate,” “believe,” “target,” “expect,” and statements in the future tense are generally forward-looking. The achievement or success of the matters covered by such forward-looking statements involves significant risks, uncertainties, and assumptions. Undue reliance should not be placed on such forward-looking statements, which are based on information available to us on the date hereof. We assume no obligation to update such statements. More information about these risks, uncertainties, and assumptions is or will be described in greater detail in our public filings with the Securities and Exchange Commission (the “SEC”), copies of which may be obtained by visiting our Investor Relations website at http://investor.zynga.com or the SEC’s website at www.sec.gov.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210527005009/en/
Contact information
Sarah Ross (sarah@zynga.com)
Dana Whitney (dwhitney@zynga.com)
Kenny Johnston (kjohnston@zynga.com)
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
